← All trials
NCT01318733
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2011
- Primary completion
- Jun 1, 2012
- Completion date
- Jul 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 449
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- GaldermaLead sponsor
- Tennessee Clinical Research CenterOverall official - principal investigator
- Dermatology, Laser & Vein Specialists of the CarolinasOverall official - principal investigator
- Longmont Clinical PCOverall official - principal investigator
- Dermatology Clinical Research Center of San AntonioOverall official - principal investigator
- East Tennessee Medical ResearchOverall official - principal investigator
- Hamzavi DermatologyOverall official - principal investigator
- Rivergate Dermatology Clinical Research Center, PLLCOverall official - principal investigator
- Cherry Creek Research, Inc.Overall official - principal investigator
- Arlington Center for DermatologyOverall official - principal investigator
- Metrolina Medical ResearchOverall official - principal investigator
- DermDoxOverall official - principal investigator
- Deaconess ClinicOverall official - principal investigator
- Minnesota Clinical Study CenterOverall official - principal investigator
- The Laser Institute for DermatologyOverall official - principal investigator
- Madison Skin & Research, Inc.Overall official - principal investigator
- TriCities Medical ResearchOverall official - principal investigator
- Derm Research IncorporatedOverall official - principal investigator
- Gwinnett Clinical Research Center, IncOverall official - principal investigator
- PMG ResearchOverall official - principal investigator
- Amanda Tauscher, MDOverall official - principal investigator
- Vitalink ResearchOverall official - principal investigator
- Somerset Skin CentreOverall official - principal investigator
- Progressive Clinical ResearchOverall official - principal investigator
- Wenatchee Valley Medical CenterOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.